These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 12115175)

  • 1. Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis.
    Munster T; Gibbs JP; Shen D; Baethge BA; Botstein GR; Caldwell J; Dietz F; Ettlinger R; Golden HE; Lindsley H; McLaughlin GE; Moreland LW; Roberts WN; Rooney TW; Rothschild B; Sack M; Sebba AI; Weisman M; Welch KE; Yocum D; Furst DE
    Arthritis Rheum; 2002 Jun; 46(6):1460-9. PubMed ID: 12115175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Related to Blood Hydroxychloroquine Concentration in Patients With Systemic Lupus Erythematosus.
    Yeon Lee J; Lee J; Ki Kwok S; Hyeon Ju J; Su Park K; Park SH
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):536-542. PubMed ID: 27390146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood concentrations of hydroxychloroquine and its desethyl derivative correlate negatively with the percentage of CD45RO+ cells among CD4+ lymphocytes in hydroxychloroquine-treated lupus patients.
    Sailler L; Puissant B; Méliani P; Castex JO; Saivin S; Adoue D; Fournie B; Arlet P; Montastruc JL; Lapeyre-Mestre M; Pourrat J; Blancher A
    Ann N Y Acad Sci; 2007 Jun; 1108():41-50. PubMed ID: 17893969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension.
    Furst DE; Lindsley H; Baethge B; Botstein GR; Caldwell J; Dietz F; Ettlinger R; Golden HE; McLaughlin GE; Moreland LW; Roberts WN; Rooney TW; Rothschild B; Sack M; Sebba AI; Weisman M; Welch KE; Yocum D
    Arthritis Rheum; 1999 Feb; 42(2):357-65. PubMed ID: 10025931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of an LC-MS/MS method for determination of hydroxychloroquine, its two metabolites, and azithromycin in EDTA-treated human plasma.
    Sok V; Marzan F; Gingrich D; Aweeka F; Huang L
    PLoS One; 2021; 16(3):e0247356. PubMed ID: 33667247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Polymorphisms of Cytochrome P450 2D6 With Blood Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus.
    Lee JY; Vinayagamoorthy N; Han K; Kwok SK; Ju JH; Park KS; Jung SH; Park SW; Chung YJ; Park SH
    Arthritis Rheumatol; 2016 Jan; 68(1):184-90. PubMed ID: 26316040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presumable effects of hydroxychloroquine and its metabolites in the treatment of systemic lupus erythematosus.
    Pan M; Jin R; Dai Y; Gao B; Liu Y; Peng X; Qiao J; Shuai Z
    Int Immunopharmacol; 2024 Jan; 126():111269. PubMed ID: 38006753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
    Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
    Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the stereoisomers of hydroxychloroquine and its major metabolites in plasma and urine following a single oral administration of racemic hydroxychloroquine.
    Iredale J; Fieger H; Wainer IW
    Semin Arthritis Rheum; 1993 Oct; 23(2 Suppl 1):74-81. PubMed ID: 8278822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of a Fast Ultra-High Performance Liquid Chromatography-Fluorescent Method for the Quantification of Hydroxychloroquine and Its Metabolites in Patients With Lupus.
    Noé G; Amoura Z; Combarel D; Lori L; Tissot N; Seycha A; Funck-Brentano C; Zahr N
    Ther Drug Monit; 2019 Aug; 41(4):476-482. PubMed ID: 30807538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin and ophthalmic complications of chloroquine and hydroxychloroquine in patients with rheumatoid arthritis and systemic lupus erythematous.
    Zamani B; Hasan-Abad AM; Rafizadeh SM; Akbari H; Motedayyen H
    J Immunoassay Immunochem; 2024 May; 45(3):178-188. PubMed ID: 38722204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enantioselective determination of hydroxychloroquine and its major metabolites in urine and the observation of a reversal in the (+)/(-)-hydroxychloroquine ratio.
    Fieger H; Iredale J; Wainer IW
    Chirality; 1993; 5(2):65-70. PubMed ID: 8343344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease.
    Iudici M; Pantano I; Fasano S; Pierro L; Charlier B; Pingeon M; Dal Piaz F; Filippelli A; Izzo V
    Lupus; 2018 Feb; 27(2):265-272. PubMed ID: 28659047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Capillary Electrophoresis-Based Method for the Measurement of Hydroxychloroquine and Its Active Metabolite Desethyl Hydroxychloroquine in Whole Blood in Patients with Rheumatoid Arthritis.
    Sotgia S; Zinellu A; Mundula N; Mangoni AA; Carru C; Erre GL
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35745021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective determination of hydroxychloroquine and its metabolites in human urine by liquid-phase microextraction and CE.
    de Oliveira AR; Cardoso CD; Bonato PS
    Electrophoresis; 2007 Apr; 28(7):1081-91. PubMed ID: 17295421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of hydroxychloroquine and its major metabolites in plasma using sequential achiral-chiral high-performance liquid chromatography.
    Iredale J; Wainer IW
    J Chromatogr; 1992 Jan; 573(2):253-8. PubMed ID: 1601957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A linked physiologically based pharmacokinetic model for hydroxychloroquine and metabolite desethylhydroxychloroquine in SARS-CoV-2(-)/(+) populations.
    Steinbronn C; Chhonker YS; Stewart J; Leingang H; Heller KB; Krows ML; Paasche-Orlow M; Bershteyn A; Stankiewicz Karita HC; Agrawal V; Laufer M; Landovitz R; Wener M; Murry DJ; Johnston C; Barnabas RV; Arnold SLM
    Clin Transl Sci; 2023 Jul; 16(7):1243-1257. PubMed ID: 37118968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial--an Indian experience.
    Das SK; Pareek A; Mathur DS; Wanchu A; Srivastava R; Agarwal GG; Chauhan RS
    Curr Med Res Opin; 2007 Sep; 23(9):2227-34. PubMed ID: 17692155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus.
    Jallouli M; Galicier L; Zahr N; Aumaître O; Francès C; Le Guern V; Lioté F; Smail A; Limal N; Perard L; Desmurs-Clavel H; Le Thi Huong D; Asli B; Kahn JE; Pourrat J; Sailler L; Ackermann F; Papo T; Sacré K; Fain O; Stirnemann J; Cacoub P; Leroux G; Cohen-Bittan J; Sellam J; Mariette X; Blanchet B; Hulot JS; Amoura Z; Piette JC; Costedoat-Chalumeau N;
    Arthritis Rheumatol; 2015 May; 67(8):2176-84. PubMed ID: 25989906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis.
    Carmichael SJ; Charles B; Tett SE
    Ther Drug Monit; 2003 Dec; 25(6):671-81. PubMed ID: 14639053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.